Research demonstrates value of Volpara Solutions' breast density assessment to help improve breast cancer risk prediction models
12/30/2014

The value of volumetric breast density to help improve breast cancer risk prediction models and monitor clinical treatment was the focus of numerous abstracts presented at the 2014 San Antonio...

FDA approves Lynparza to treat advanced ovarian cancer
12/30/2014

The U.S. Food and Drug Administration has granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as...

Mutations prevent programmed cell death in lymphoma
12/30/2014

Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves.

Trial finds cancer drug can block key signal in cancer growth and drug resistance
12/30/2014

An experimental cancer drug may block an important driver for the survival, growth and spread of cancer cells.

CancerStories launches the world's first ehealth app to support cancer patients and families
12/30/2014

The world's first ehealth app to support cancer patients and families has been launched.

A link discovered between ferrets and humans which could lead to improved therapies for a range of diseases
12/30/2014

Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.

Specific oxidation regulates cellular functions
12/30/2014

Hydrogen peroxide (H2O2) is a strong oxidizer and is used as a bleaching agent for hair and teeth, and as a wound disinfectant.

Animal-specific sugar may drive cancer risk in people who eat red meat
12/30/2014

In a mouse model, scientists have found that consumption of the sugar Neu5Gc - found typically in beef, pork and lamb - may promote cancer-causing inflammation.

Health systems explore how to meet the needs of an increasing number of breast cancer survivors
12/30/2014

More women are surviving breast cancer - and living longer - but the number of oncologists has remained steady, leaving a gap in care for many of the over 2.

FDA approves pathogen reduction system to treat platelets
12/30/2014

The U.S. Food and Drug Administration has approved the Intercept Blood System for platelets, the first pathogen reduction system to treat single donor apheresis platelets.